Csi CE 5/23 sda f 1/23

This tender concerns the award of a specific contract by the Consorci Sanitari Integral (CSI). The contract is derived from a Dynamic Procurement System (DPS) and focuses on the supply of a specific, exclusive medication: TEZEPELUMAB 210 MG. The medication is presented in an injectable form, specifically a 1.91 ml pre-filled pen. The CSI, a healthcare consortium, is seeking to secure a reliable supply of this essential drug. The use of a Dynamic Procurement System suggests a streamlined and potentially ongoing procurement process, allowing qualified suppliers to bid for contracts as needed. This award indicates that a selection has been made from the suppliers registered within the DPS for this particular medication. The tender details would typically include the awarded supplier, the contract value, the duration of the supply agreement, and the specific quantities of TEZEPELUMAB to be provided. This procurement is crucial for ensuring patient access to this exclusive treatment within the healthcare services managed by the Consorci Sanitari Integral.

This is a supplies contract in the health and medical services and general supplies sectors, with a focus on Pharmaceuticals. Located in Spain, Europe, this opportunity is open to firms and consortiums.

Published through TED - Tenders Electronic Daily (EU), a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.